K
aposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), is a member of the gammaherpesvirus family, which includes Epstein-Barr virus (EBV), herpesvirus saimiri (HVS), and murine herpesvirus 68 (MHV 68) (1) . KSHV is the etiological agent of Kaposi's sarcoma (KS), the most common tumor associated with HIV infection, and with at least two other malignancies, pleural effusion lymphoma (PEL) and multicentric Castleman's disease (MCD) (2) (3) (4) . Like all herpesviruses, the life cycle of KSHV consists of latent and lytic phases. The latent phase is characterized by a restricted pattern of viral gene expression that facilitates the evasion of immune surveillance and the establishment of lifelong persistent infection. The lytic phase drives the replication cycle, and a majority of the viral genes are expressed in this phase. This phase mainly allows for the spread of the virus in the infected individual. A growing body of research suggests that both latent and lytic replication phases play an important role in the pathogenesis of KS (5) .
The transition from latency to lytic replication is controlled by the KSHV replication and transcription activator (K-Rta) gene, an immediately-early (IE) gene carried by open reading frame 50 (ORF50). K-Rta expression has been found to be essential and sufficient to trigger lytic replication by activating the lytic gene expression cascade (6) (7) (8) . Genetic knockout of K-Rta resulted in a null phenotype in viral DNA synthesis and in virus production (9) . K-Rta is a 691-amino-acid (aa)-long transcriptional factor that contains an N-terminal DNA-binding domain and a C-terminal activation domain. K-Rta can trigger KSHV lytic reactivation via transcriptional activation of a number of viral lytic promoters, by binding either directly to the promoter DNA or indirectly via interaction with cellular DNA binding proteins (10) (11) (12) (13) (14) (15) .
There is a complex interplay between herpesvirus lytic replication and host cell cycle arrest. Previous studies investigating the role of cell cycle in herpesvirus lytic replication suggested that host cell cycle arrest precedes the induction of the lytic cycle and essentially determines whether immediate-early gene expression is initiated or not (16) . However, current research increasingly supports the idea that cell cycle arrest follows lytic cycle induction and is a direct consequence of immediate-early gene expression (17) (18) (19) . It is hypothesized that arresting cells during early lytic replication is a common evolutionary strategy employed by herpesviruses to avoid competition for resources required for viral DNA replication with the host in the S phase, or it may serve to prevent premature apoptosis during lytic replication (20) . This is in contrast to small DNA viruses, especially those lacking their own polymerase, like simian virus 40 (SV40) and adenoviruses, which actively drive host cells into the S phase of the cell cycle in order to replicate their genome at the same time with host DNA synthesis. Arresting cell growth early during infection/reactivation may also be a strategy to avoid being killed by cytotoxic T cells, as it has been reported that noncycling cells are refractory to killing by cytotoxic T cells (21) . To date, several herpesvirus-encoded proteins have been identified that participate in arresting host cell growth. These proteins are virion components and/or immediate-early transcriptional factors. For example, the IE product of herpes simplex virus, ICPO, has been found to arrest the cell cycle in G 1 phase by both p53-mediated and p53-independent pathways (22, 23) . In the case of EBV, the immediate-early product Zta can induce host cell cycle arrest by stabilizing p53 and p27 and also through repressing the expression of c-myc (24, 25) . Furthermore, it has been shown that Zta may cooperate with host transcriptional factor C/EBP to upregulate p21, which in turn results in cell cycle arrest (26) .
Among the characterized early genes of KSHV, K8, or K-bZIP protein, a functional homologue of EBV's immediate-early Zta protein, was shown to arrest PEL cells in G 1 phase during the lytic cycle by upregulating C/EBP and p21 proteins (27) . K8 was also found to inhibit kinase activities of CDK2 by directly binding through its bZIP domain (17) . However, the role of KSHV-encoded ORF50/K-Rta, one of the first genes transcribed and the central regulator for the initiation of the lytic replication cycle, in cell cycle regulation has not been evaluated. In the present study, we demonstrated that K-Rta induces cell cycle arrest in an inducible BJAB cell model, and this growth arrest is mediated by elevated levels of p27, a central cyclin-dependent kinase inhibitor (CDKI). Our results shed new light on the biological function of K-Rta as a key cell cycle regulator early during viral reactivation, in addition to being a transcriptional regulator.
MATERIALS AND METHODS
Cell culture plasmids and transfection. 293T cells, a 293-based doxycycline-inducible K-Rta cell line (TREx293Rta) (provided by Yoshihiro Izumiya, University of California at Davis, Davis, CA), and Vero cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT) and 100 g/ml penicillin-streptomycin (Mediatech). DG75 is an EBV-negative Burkitt's lymphoma (BL)-derived B-cell line (provided by Luwen Zhang, University of Nebraska-Lincoln, Lincoln, NE). It was grown in RPMI 1640 medium (Gibco BRL) supplemented with 10% FBS and 100 g/ml penicillin-streptomycin. TRExBJABRta and TRExBJAB cells are BJAB (EBV-and KSHV-negative B-cell line)-derived cell lines with or without the doxycycline-inducible K-Rta gene. They were provided by Jae Jung (University of Southern California, Los Angeles, CA) (28) and were grown in RPMI 1640 medium supplemented with 10% FBS, 100 g/ml penicillin-streptomycin, and 200 g/ml of hygromycin B. KSHV-positive and EBV-negative B-cell lines, BC3 cells (ATCC), and Cro6 cells (29) (provided by Luwen Zhang, University of NebraskaLincoln, Lincoln, NE) were grown in RPMI 1640 medium (ATCC) supplemented with 20% FBS and 100 g/ml penicillin-streptomycin. Human microvascular endothelial cells (HMVEC) were grown in endothelial basal medium-2 (EBM-2) (Lonza, Boston, MA) supplemented with 10% fetal bovine serum (FBS), 100 g/ml penicillin-streptomycin, 0.01 g/ml epidermal growth factor, and 1 g/ml hydrocortisone (30) . All cultures were incubated at 37°C with 5% CO 2 .
K-Rta expression plasmid (pCMVtagORF50), which encodes Flagtagged full-length Rta, and pCMVtagORF50(1-527), which encodes truncated K-Rta (amino acids [aa] 1 to 527), were described previously (31) . The transfection of 293T cells and Vero cells was carried out using Lipofectamine 2000 (Invitrogen) or Fugene 6 (Promega) according to the manufacturer's recommendations. The transfection of DG75 cells was carried out using the nucleofection protocol according to the manufacturer's protocols (solution V and program O-006; Amaxa Biosystems).
Cell cycle analysis. Cell cycle profiles were analyzed by flow cytometry with standard propidium iodide (PI) staining methods (32) . Asynchronized and synchronized cells were harvested at the given time points, washed once with PBS, and fixed in 70% ethanol at Ϫ20°C. After collection of samples from all time points, the cells were washed with PBS twice and resuspended in PBS containing PI (Roche) at a final concentration of 10 g/ml and RNase A (20 g/ml). The samples were kept at room temperature for 30 min in the dark, and 20,000 events per sample were acquired using a FACSCalibur flow cytometer (BD Biosciences). The data were analyzed using Modfit LT version 2.0 software (Verity Software House Inc.).
RNA extraction and RT-PCR. Total cellular RNA was extracted using an RNeasy kit (Qiagen) according to the manufacturer's procedures. RNA samples were digested with DNase (Invitrogen) to remove any residual DNA. Total RNA (2 g) was used for reverse transcription (RT) using oligo(dT) as the primers and a Superscript II reverse transcriptase kit (Invitrogen, Inc., Carlsbad, CA) according to the manufacturer's instructions. The primers used for the mRNA quantitation were the following: p27 (F), 5-CGTCAAACGTAAACAGCTCG-3; p27 (R), 5-CATTCCATG AAGTCAGCGAT-3; ORF50 (F), 5-CAAACCCCATCCCAACAT-3; ORF50 (R), 5-AGTAATCACGGCCCCTT-3; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (F), 5-CCATGGAGAAGGCTGGGG-3; and GAPDH (R), 5-CAAAGTTGTCATGGATGACC-3. These target genes were amplified using the iQ SYBR green real-time master mix (BioRad) in a Bio-Rad iCyclerIQ thermocycler. All reactions were performed in triplicate using the following conditions: 50°C for 2 min, 95°C for 10 min, 40 cycles of 95°C for 15 s, and 60°C for 1 min. Melting-curve data for all of the samples were obtained to ensure specific amplification. All reactions were performed in triplicate and included no-template controls for each gene. The experiments were repeated 2 times using samples in triplicate. Relative gene expression was calculated using the delta delta threshold cycle (⌬⌬C T ) method (33) . For calculating relative mRNA levels, the C T value of each gene was normalized to the C T value of GAPDH, and the normalized C T values from samples were compared to those of the control samples (untreated).
Immunoprecipitation and immunoblot analysis. Total cell lysates for immunoprecipitation and Western blotting were prepared in radioimmunoprecipitation assay buffer (RIPA) (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1% NP-40) supplemented with protease and phosphatase inhibitor cocktail (Pierce). The lysates were kept on ice for 30 min with occasional vortexing. Finally, the lysates were centrifuged for 15 min at 13,000 ϫ g at 4°C and the supernatant was collected. Cytosolic and nuclear proteins were extracted from TRExBJABRta cells using a SigmaCelLytic NuCLEAR extraction kit by using the manufacturer's protocol. The protein concentration was measured using a bicinchoninic acid (BCA) protein kit (Pierce, Rockford, IL). For immunoprecipitation, equal amounts of lysate from each treatment were precleared with 20 l of protein A/G Sepharose (1 h, 4°C). Five percent of the precleared lysate was saved as the input control, and the total amount of p27 was captured by incubation with 2 g of anti-p27 (SC-1641; Santa Cruz) antibody overnight at 4°C. Immune complexes were captured with 30 l of a 1:1 mixture of protein A and protein G Sepharose beads (Pierce, Rockford, IL) for 2 h. The beads were then pelleted and washed three times with ice-cold radioimmunoprecipitation assay (RIPA) buffer. The immunoprecipitated proteins were eluted by heating in 2ϫ sample buffer and subjected to immunoblotting.
For immunoblotting, equal amounts of total proteins (40 g) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and subsequently transferred to nitrocellulose membranes using standard methods. After blocking with 5% nonfat dry milk in Trisbuffered saline (TBS) (20 mM Tris, pH 7.4, 137 mM NaCl) containing 0.01% Tween 20 (TBST) for 1 h, the membrane was incubated with primary antibody overnight at 4°C. Following washing with TBST three times, the membrane was incubated with horse peroxidase-conjugated goat anti-rabbit/mouse secondary antibody (1:10,000; Pierce) or infraredtagged secondary antibodies (1:10,000; Licor Inc., Lincoln, NE) for 30 min. Antibody binding was detected using SuperSignal West Dura extended duration substrate kit (Pierce) or using an Odyssey imager. Image analysis and quantification of immunoreactive bands was performed using the Odyssey Infrared Imaging System application software (LiCor Inc., Lincoln, NE) or NIH ImageJ software.
The following antibodies were used in the present study: anti-rabbit K-Rta antibody was a kind gift from Y. Izumiya (UC Davis, CA) and was used at a dilution of 1:5,000. Anti-rabbit p27 (SC-528), anti-mouse p27 (SC-1641), anti-rabbit p21 (SC-397), anti-rabbit Rb (pS807/pS811) (BD558389), anti-rabbit cyclin A (SC-751), anti-mouse GAPDH (SC-32233), anti-mouse ubiquitin (UB) (SC-8017), anti-rabbit Skp2 (H-435), anti-pp27-T187 (Ab75908), anti-mouse TATA binding protein (Ab818), and anti-mouse ␣ tubulin (SC-5286) were used at a 1:1,000 dilution in TBST. Protein stability test. Exponentially growing TRExBJABRta cells were cultured in the presence of doxycycline (DOX) for 24 h. DOX-treated and untreated cells were treated with 50 g/ml cycloheximide (CHX) (SigmaAldrich, St. Louis, MO). The cells were harvested at the indicated time points after CHX treatment, and cell lysates were subjected to Western blot analysis. Band intensities were quantitated using Odyssey 3.0 software provided with the Odyssey imager (LiCor Inc., Lincoln, NE), and the half-life of p27 protein was calculated from the slope of the curve.
Immunofluorescence assay. TRExBJABRta cells were treated with doxycycline for 48 h. The cells were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 in phosphate-buffered saline (PBS) for 10 min, and blocked for 30 min with 2% bovine serum albumin (BSA) in PBS at room temperature. After incubation with primary antibodies (anti-p27 mouse monoclonal [BD] and anti-rabbit KRta), both at 1:250 dilution in 2% BSA for 2 h at room temperature, the cells were incubated with anti-mouse Alexa Fluor 488-and anti-rabbit Alexa Fluor 647-conjugated secondary antibodies (1:1,000) for 1 h at room temperature. This was followed by three washes with PBS. The last wash contained 4=,6-diamidino-2-phenylindole (DAPI) (Calbiochem) to counterstain nuclei. The localization of K-Rta/p27 and DAPI-stained nuclei was visualized by confocal microscopy.
Lentivirus-based short hairpin RNA (shRNA) knockdown of p27. To establish a p27 knockdown cell line, plasmids encoding p27 shRNA (1 and 2) and scrambled negative-control shRNA (1 and 2) were purchased from Origene and were transfected into TRExBJABRta cells using the Nucleofector kit T from Lonza (Walkersville, MD) according to the manufacturer's procedure (program G-016). The transfected cells were selected with puromycin (1 g/ml) for 3 weeks.
Lentivirus vector expressing full-length K-Rta, virus production, and transduction of HMVEC cells. To generate a lentiviral vector expressing KSHV full-length Rta, the coding sequence was cloned into pLVX-AcGFP1 (Clontech). The vesicular stomatitis virus protein G (VSV-G)-pseudotyped lentiviral particles were produced by transient cotransfection of 293T cells as described previously (34) . Briefly, 5 ϫ 10 6 to 6 ϫ 10 6 HEK293T cells were cotransfected with 18 g of K-Rta-expressing transfer vector (pLVX-Rta), 12 g packaging vector psPAX2, and 6 g of envelope vector pHEF-VSVG per 10-cm-diameter plate at a 3:2:1 mass ratio by using a standard calcium phosphate coprecipitation method. Eight hours posttransfection, the medium was replaced with DMEM supplemented with 10% FBS. The medium containing the virus was harvested 48 h posttransfection, filtered through a 0.45-m pore filter, and concentrated by ultracentrifugation at 4°C for 2 h at 25,000 rpm with a T-865 rotor (Sorvall). Pellets were gently resuspended in DMEM and kept overnight at 4°C. The viral titers of concentrated pseudotyped lentiviruses were determined by transducing 3 ϫ 10 5 293T cells seeded in one well of a 6-well plate in 4 ml of medium containing 8 g/ml of Polybrene (Sigma). The medium was replaced after 6 h. After 48 h the number of cells expressing green fluorescent protein (GFP) was determined using flow cytometry. The viral titers were calculated using the formula (N ϫ M)/V, where N is the number of target cells used for infection, M is percent GFP-expressing cells, and V is the volume of concentrated virus used (in ml).
Statistical analysis. All data analysis was done using SPSS software (v11). Comparison of mean numbers of cells was done using Student's t test. All P values of Յ0.05 were considered significant.
RESULTS
Expression of K-Rta induces cell cycle arrest in G 1 phase. Earlier investigations have reported that tetradecanoyl phorbol acetate (TPA)-induced reactivation of KSHV results in cell cycle arrest in G 1 phase of the treated cells and implicated the early lytic gene product K-bZIP for the induction of cell cycle arrest (17) . Indeed, TPA treatment of asynchronously growing BC3 cells (KSHV-positive latent B-cell line) resulted in a marked increase of cells in the G 1 fraction at 24 h after treatment, from 37 (before treatment) to 56.5%. This increase in proportion of cells arrested in G 1 phase was also noted after TPA treatment of another KSHV-positive latent B-cell line, Cro6, with a significant increase from 55.6% (before treatment) to 70.5% at 24 h posttreatment. However, TPA-induced G 1 arrest was not observed in the KSHV negativecontrol B-cell line DG75 at 24 h post-TPA treatment (Fig. 1) . These results confirmed previous findings that KSHV lytic reactivation arrests naturally infected B cells in G 1 phase.
Since G 1 arrest is favored after lytic replication, we sought to investigate whether any other immediate-early genes besides KbZIP was involved in cell cycle arrest. We hypothesized that K-Rta, being the central regulator of the viral lytic cycle and one of the very first genes to be transcribed following reactivation, works in concert with K-bZIP to arrest the cell cycle in G 1 phase. To investigate K-Rta's role in cell cycle regulation, we utilized TRExBJABRta cells in which the myc-tagged full-length K-Rta gene is integrated into the chromosomal DNA under the control of a tetracycline-inducible promoter. Asynchronously growing exponential-phase cultures of TRExBJAB (control) and TRExBJABRta were synchronized in G 0 /G 1 phase by serum starvation. The cells were released from growth arrest with the addition of medium containing 10% serum along with doxycycline. We then quantitated the fraction of cells in different phases of the cell cycle by flow cytometry at 24, 48, and 72 h post-Dox treatment for both TRExBJAB and TRExBJABRta cells. The fraction of cells arrested in G 0 /G 1 phase after 24 h of serum starvation treatment was about 53% for both cell lines. Serum starvation for an extended time was avoided, as it affected cell viability. The cell cycle profiles of both cell lines were similar following release from serum starvation without Dox treatment and showed enrichment of cells in S phase over time (data not shown). Interestingly, the cell cycle profile clearly showed a significant increase in the number of cells arrested at G 1 phase in TRExBJABRta cells compared to control TRExBJAB cells at 48 h (P ϭ 0.006) and 72 h (P Ͻ 0.001) post-Dox treatment ( Fig. 2A) . In contrast, there were more cells in S phase for TRExBJAB cells after 48 and 72 h of Dox treatment, demonstrating that doxycycline alone has little or no effect on cell cycle progression following the release of cell cycle arrest in the absence of K-Rta. A significant arrest in G 1 phase was also noted for Dox-treated TREx293Rta cells at 72 h posttreatment compared to untreated cells (P Ͻ 0.001) (Fig.  2B) , further supporting the data observed for BJAB cells. These results clearly show that the expression of K-Rta alone can induce cell cycle arrest in G 1 phase.
K-Rta expression led to a decrease in phosphorylated Rb and a parallel increase in p27 kip1 protein levels. To explore the underlying mechanism of K-Rta-mediated cell cycle arrest, the expression kinetics of key cell cycle regulators were analyzed by Western blotting. Whole-cell lysates were prepared from Doxtreated and untreated TRExBJAB and TRExBJABRta cells. First, we investigated the phosphorylation status of retinoblastoma (Rb) protein, a critical negative regulator of the cell cycle that undergoes differential phosphorylation during the cell cycle (35) . In early G 1 phase, Rb is largely dephosphorylated and bound to the E2F family of transcriptional factors, forming a repressor complex. However, upon phosphorylation by Cdk4/6/cyclin D complex during early G 1 phase and further by Cdk2/cyclin E during late G 1 phase, Rb dissociates from E2F, activating the expression of proteins needed for S phase entry and progression (35) . We examined the status of Rb phosphorylation using an antibody that recognizes Rb phosphorylated at Ser807/Ser811. These sites are the target sites of Cdk4/6/cyclin D complex during G 1 phase. Induction of K-Rta in TRExBJABRta cells resulted in a significant decrease in the phosphorylated levels of Rb, most notably at 48 and 72 h post-Dox treatment (Fig. 3A) . The results were markedly different in Dox-untreated TRExBJABRta cells, which displayed a significant increase in the levels of phosphorylated Rb in a timedependent manner that reached peak expression by 48 h, indicating that most of these cells were actively progressing through the cell cycle. In control TRExBJAB cells, the levels of phosphorylated Rb increased in a time-dependent manner following release from cell cycle arrest irrespective of Dox treatment, suggesting that Dox treatment alone did not affect the normal cell cycle progression. Cyclin A is a useful marker for the S phase, as its expression increases during cell cycle progression (36) . Cyclin A expression in both cell lines, with or without Dox treatment, followed expression kinetics similar to those of phosphorylated Rb.
Since the activities of G 1 cyclin-CDK complexes are mainly regulated by the Cip/Kip family of cyclin-dependent kinase inhibitors (CDKIs), we aimed to evaluate the expression profile of p21 and p27, two central regulators of cell cycle progression that inhibit a broad range of cyclin Cdk complexes. The levels of p27 significantly increased over time in Dox-treated TRExBJABRta cells, but the kinetics of p27 protein accumulation lagged by about 24 h following the expression of Rta in TRExBJABRta cells, reaching maximum levels at 48 h (ϳ5ϫ above background), whereas in untreated cells, p27 levels decreased in a time-dependent manner. In TRExBJAB cells, the expression kinetics of p27 was similar in both Dox-treated and untreated cells and was consistent with those described for cells entering S phase following cell cycle arrest in G 1 phase. The levels of p21 remained largely unchanged during the course of the experiment for both cell lines irrespective of Dox treatment. Since p21 is a direct transcriptional target of p53, we also investigated the expression levels of p53 and found no significant change in the relative levels of p53 in both cell lines with or without Dox treatment (data not shown). These results demonstrated that K-Rta-mediated cell cycle arrest in BJAB cells does not involve p21 and is associated with a decrease in Rb phosphorylation and a parallel increase in p27 levels.
We also examined the expression of p27 in TPA-treated BC3 cells and found that p27 levels increased in a time-dependent manner following reactivation (Fig. 3B ). This increase in p27 levels was not observed in TPA-treated DG75 cells. Although this increase in p27 levels in TPA-treated BC3 cells does not directly implicate K-Rta, it does show that cell cycle arrest during reactivation of KSHV from a latently infected B-cell line is associated with an increase in p27 levels.
To ensure that K-Rta-mediated upregulation of p27 in the BJAB cell line was not a cell type-specific effect, we transiently transfected or transduced K-Rta in DG75 cells, Vero cells, and HMVEC and checked the levels of p27 at 36 h posttransfection/ transduction by Western blotting (Fig. 3C) while the cells were actively growing at log phase. We found increased levels of p27 in cells that were transfected or transduced with K-Rta compared to cells that were transfected/transduced with vector or control virus. These results suggest that an increase in p27 levels following K-Rta expression is not unique to BJAB cells.
K-Rta does not affect p27 at the transcriptional level. Since K-Rta is a transcriptional factor and has the ability to regulate the expression of cellular genes (37), we investigated the possibility that the increased level of p27 in K-Rta-expressing cells is due to transcriptional upregulation of p27 by K-Rta. Real-time PCR was carried out with RNA samples extracted from Dox-treated and untreated cells. As shown in Fig. 4A , the level of p27 mRNA after normalization with GAPDH showed no significant difference before and after K-Rta induction. The data suggest that the upregulation of p27 in K-Rta-expressing cells is not due to increased p27 mRNA expression. These results were also supported by increased p27 levels observed in cells transiently transfected with K-Rta lacking the transactivation domain, suggesting that K-Rta does not act directly on p27 at the transcriptional level or the ability of K-Rta to upregulate p27 is independent of its transactivation function (Fig. 4B) .
K-Rta expression results in stabilization of p27.
Since p27 is mainly regulated at the posttranslational level via the ubiquitinproteasome pathway (38, 39), we examined the effect of K-Rta on the half-life of p27. Protein synthesis was blocked in K-Rta-expressing BJAB cells by cycloheximide, and p27 protein levels were quantitated at various time intervals by immunoblotting (Fig.  5A) . As a control, we also monitored p27 levels in TRExBJABRta cells that were not treated with Dox. In control cells, the half-life of p27 was found to be approximately 4.1 h, but in K-Rta-expressing cells the half-life of p27 increased to approximately 7.3 h. The data suggest that upregulation of p27 in K-Rta-expressing cells most likely is mediated by changes in protein stability. We next investigated the possibility that reduced polyubiquitination of p27 in K-Rta-expressing cells is responsible for increased levels of p27. Polyubiquitination of p27 was assessed by immunoprecipitating p27 from Dox-treated and untreated TRExBJABRta cells followed by immunoblotting (Fig. 5B) . As expected, there was an increase in p27 levels in K-Rta-expressing cells in both lysate and immu- noprecipitate lanes; however, we detected decreased levels of ubiquitinated p27 in Dox-treated TRExBJABRta cells, as evidenced by a reduction of the smear of high-molecular-weight p27 bands compared to those for the uninduced Dox lane. These results suggest that the expression of K-Rta increases p27 stability by inhibiting the polyubiquitination and subsequent proteasomal degradation.
K-Rta promotes nuclear localization of p27. The activity of p27 is also regulated by its subcellular localization, as it shuttles between nucleus and cytoplasm during the cell cycle (40) . p27 is exclusively nuclear during G 0 /G 1 phase but is exported to the cytoplasm in response to proliferating signals. Since the subcellular localization of p27 is inherently linked to the regulation of p27 activity, we determined whether K-Rta modulates the subcellular localization of p27. The localization of endogenous p27 was investigated in Dox-treated and untreated TRExBJABRta cells by indirect immunofluorescence assay. Figure 6A shows a representative field of immunostaining. As expected, intense staining, suggesting higher p27 expression levels, was observed in most K-Rtaexpressing cells. Further, the staining for p27 was predominantly nuclear and colocalized with K-Rta. In most of the untreated TRExBJABRta cells, the staining for p27 was less intense and mostly diffuse. In order to confirm the effects of K-Rta on p27 localization observed in the immunofluorescence assay, we performed cell fractionation to determine the levels of p27 in nuclear and cytosolic extracts of untreated and treated TRExBJABRta cells by Western blotting (Fig. 6B) . We found a significant fraction of p27 in the nuclear extracts (normalized to the total p27 levels) of K-Rta-expressing BJAB cells (43% versus 14%) compared to the control cells. These results demonstrate that in addition to increased stability of p27, modulation of the intracellular localization of p27 also occurred in K-Rta-induced G 1 arrest.
K-Rta-induced cell cycle arrest coincides with downregulation of Skp2. Multiple degradation pathways that regulate p27 protein levels have been characterized in recent years (39) . One of the best-understood pathways for degradation of p27 is mediated by SCF/Skp2 complex in late G 1 phase and early S phase (41) . CDK2-dependent phosphorylation at T187 targets p27 to the SCF/Skp2 complex for ubiquitin-dependent degradation (42) . CDK2-dependent phosphorylation at T187 and binding of phosphorylated p27 to Skp2 are both considered rate-limiting steps for p27 ubiquitination and subsequent degradation (43, 44) . We examined both of these events to better define the mechanism of K-Rta-mediated upregulation of p27. Figure 7 shows the kinetics of Spk2 and p27 phosphorylated at T187 from Dox-treated and untreated TRExBJABRta cells at various time intervals following release of cell cycle arrest. Skp2 levels decreased over time with kinetics that parallel the increase in the levels of p27 in K-Rtaexpressing cells. TRExBJABRta cells not treated with Dox had the opposite kinetics, with gradual accumulation of Skp2 over time. In K-Rta-expressing cells, there was a decrease in the level of p27 phosphorylation at T187 and a parallel increase in the total p27 levels. However, in cells not treated with Dox, the level of phosphorylated p27 at T187 gradually increased over time, with a parallel decrease in p27 levels, as expected. These results suggest that K-Rta-mediated upregulation of p27 is a Skp2-dependent event, and T187 is the key phosphorylation site targeted.
Knockdown of p27 expression by shRNAs mitigates K-Rtainduced cell cycle arrest. The data described above strongly suggest that K-Rta-induced cell cycle arrest involved impaired degradation of p27 by Skp2, resulting in accumulation of p27 in the nucleus. To conclusively prove that the observed accumulation of p27 had a causal effect on cell cycle arrest or is directly responsible for K-Rta-mediated cell cycle arrest, we knocked down p27 expression in the TRExBJABRta cell line by stably expressing shRNAs against p27. Western blot analysis of Dox-treated TRExBJABRta cell lines expressing shRNA against p27 showed efficient but incomplete knockdown of p27 expression (ϳ80% in both clones 1 and 2) (Fig. 8A) . TRExBJABRta cell lines expressing control shRNAs (clones 1 and 2) showed no significant reduction in levels of p27 compared to the parent TRExBJABRta cell line. We next quantitated cells in G 1 phase from TRExBJABRta cells expressing these shRNAs after release from mitotic arrest and treatment with Dox. The results from fluorescence-activated cell sorting (FACS) analysis showed that the downregulation of p27 by shRNA results in a significant decrease in K-Rta-induced G 1 arrest, ϳ60% of cells in G 1 phase compared to ϳ70% of cells in G 1 phase in parent TRExBJABRta cells or TRExBJABRta cells stably expressing control shRNAs (Fig. 8B) . We did not observe total abrogation of cell cycle arrest in G 1 phase in TRExBJABRta cells expressing shRNA against p27, but we noticed a significant decrease of cells in G 1 phase compared to TRExBJABRta cells expressing control shRNA. The data suggest that the accumulation of p27 observed in K-Rta-expressing cells contributes to cell cycle arrest in G 1 .
DISCUSSION
Our study demonstrates that the KSHV immediate-early gene KRta induces cell cycle arrest in G 0 /G 1 phase in an inducible B-cell line model. Consistent with G 1 arrest, K-Rta-mediated cell cycle arrest was associated with a decrease in the protein levels for cyclin A and phosphorylated Rb, both markers of S phase progression. Importantly, our results establish p27, a critical cyclin-dependent kinase inhibitor (CDKI), as a key player in K-Rta-mediated cell cycle arrest. The central role of p27 in K-Rta-mediated G 1 arrest is supported by shRNA knockdown of p27, which significantly overrode the cell cycle arrest in K-Rta-expressing cells. Since the knockdown of p27 did not completely abolish K-Rta-mediated G 1 arrest, we cannot exclude the possibility that K-Rta also is functioning through other pathways that could contribute to cell cycle arrest.
Our finding that K-Rta arrests cells in G 0 /G 1 phase is in general agreement with recent studies that investigated the role of EBVencoded Rta (E-Rta) in cell cycle regulation (18) . The expression of inducible E-Rta in 293 and nasopharyngeal carcinoma (NPC)-derived cells resulted in G 1 arrest (18, 19) , which was associated with elevated levels of p21 and p27. However, we did not notice any significant changes in the expression of p21 in K-Rta-expressing cells. It is possible that E-Rta and K-Rta have evolved diverse mechanisms to arrest the cell cycle in G 1 phase, or these diverse pathways could be due to the different cellular contexts used in the experiments. It is interesting that the K-Rta-mediated increase in p27 levels was not at the transcriptional level and was independent of K-Rta's transactivation ability. The transactivation function of several herpesviral immediate-early genes, including Zta, IE2, and ICP0, was found to be dispensable for cell cycle arrest (25, (45) (46) (47) . Instead, the ability to arrest the cell cycle was mapped to key motifs that are involved in protein-protein interactions, like the bZIP domain of E-Zta and the RING finger domain for ICP0 (25, 45) . These studies suggest that the transactivation function of imme- diate-early genes is less important for mediating cell cycle arrest than direct interactions with key cell cycle regulators.
In normal cells, p27 levels are maximal in quiescence but fall rapidly as the cells progress from G 1 to S phase. p27 is a short-lived protein, and its levels are mainly regulated by posttranslational proteolytic degradation (39, 48) . In the late G 1 phase, degradation of p27 is mediated by SCF/Skp2 E3 ubiquitin ligase complex that requires phosphorylation of p27 at the T187 residue by the cyclin E,A/CDK2 complex (49) . The phosphorylation at T187 creates a recognition site for Skp2 complex, which induces p27 polyubiquitination and subsequent degradation by the proteasome (41) (42) (43) . The data presented here demonstrate that p27 was more stable in K-Rta-expressing cells. This finding was also supported by decreased polyubiquitination of p27 observed in K-Rta-expressing cells. It is noteworthy that p27 degradation involves both Skp2-dependent and -independent proteosomal degradation pathways (39) . We have focused on the Skp2-dependent proteosomal pathway, as it is the best-characterized and most potent degradation pathway that determines p27 stability. It remains to be clarified whether K-Rta-mediated stabilization of p27 also in- fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.2% Triton X-100 in PBS for 10 min, and blocked for 30 min with 2% bovine serum albumin (BSA) in PBS. After incubation with primary antibodies (anti-p27 and anti-Rta, both at a 1:250 dilution) in 2% BSA for 2 h at room temperature, the cells were incubated with anti-mouse Alexa Fluor 488-and anti-rabbit Alexa Fluor 647-conjugated secondary antibodies (1:1,000) for 1 h at room temperature. The Rta and p27 localization and DAPI-stained nuclei were visualized by confocal microscopy. (B) Cytosolic and nuclear fractions were extracted from TRExBJABRta cells treated with doxycycline and subjected to Western blotting with the indicated antibodies. TATA binding protein (TBP) and ␣-tubulin were used as a nuclear fraction and cytosolic fraction loading control, respectively. The bar graph on the right side shows the percentage of p27 quantitated in the nuclear fraction (normalized to total p27 levels). Gel images presented here are representative of two independent experiments. volves another degradation pathway besides the Skp2-dependent pathway that would function independently of T187 phosphorylation.
Based on our results, we hypothesize that there are at least three nonmutually exclusive possibilities by which K-Rta can induce cell cycle arrest, as summarized in Fig. 9 . First, K-Rta may sequester p27 in the nucleus to prevent its export to the cytoplasm by direct or indirect interaction. The localization of p27 seems to be finely regulated during G 1 progression (39) . To act as a cell cycle inhibitor, p27 must be localized in the nucleus, whereas its cytoplasmic export allows cell cycle progression. In our study, we observed the accumulation of p27 in the nucleus of K-Rta-expressing cells, but it is difficult to resolve whether K-Rta is directly modulating the subcellular localization of p27 or the nuclear accumulation of p27 is an indirect consequence of K-Rta-mediated cell cycle arrest. The second possibility is that K-Rta induces or represses the expression of any upstream kinase or phosphatase that may regulate the phosphorylation of p27. Several key phosphorylation sites have been characterized in recent years, including S10, T157, and T198, which determine p27 stability and subcellular localization (39) . The third possibility is that K-Rta directly or indirectly interacts with SCF/Skp2 complex to disrupt the binding between p27 and Skp2, which targets p27 for subsequent proteosomal degradation. Since K-Rta has been shown to possess E3 ubiquitin ligase activity, the last scenario becomes particularly interesting if Skp2 is identified as a target for K-Rta-mediated proteosomal degradation (50) . In that case, p27 will escape Skp2-mediated proteosomal degradation and would accumulate in the nucleus. We were able to coimmunoprecipitate overexpressed tagged versions of KRta and Skp2 in transiently transfected 293T cells (data not shown); however, our effort to detect this interaction in vivo under physiologically relevant conditions was unsuccessful. It is plausi- ble that the interaction between K-Rta and Skp2 is transient in nature and/or very weak.
Recent research suggests that KSHV lytic reactivation is tightly linked to B-cell terminal differentiation (51) . KSHV remains latent in a not very well-characterized B-cell compartment until B cells differentiate into plasma cells. This terminal differentiation provides the physiological lytic switch through plasma cell transcription factor X box binding protein 1 (XBP-1s). Thus, KSHV, like EBV, reactivates by exploiting the terminal differentiation pathway of latently infected B cells. In most cell lineages, final differentiation is associated with loss of proliferation and cell cycle arrest in G 1 phase (52) . During the differentiation process, the expression of various CDKIs, including p27, is upregulated. Strong evidence for a role of p27 in differentiation programs comes from studies of mice lacking p27, which show altered differentiation programs in various tissues (53) (54) (55) . It would be interesting to investigate whether K-Rta-mediated upregulation of p27 following lytic reactivation also plays a role in differentiation of B cells besides cell cycle arrest.
An issue that remains to be resolved is the experimental validation of the hypothesis of the presumed benefit of cell cycle arrest during KSHV or in general herpesvirus lytic replication. Most studies, including ours, have investigated the role of herpesviral immediate-early genes in cell cycle regulation in an overexpressed system. Experimental validation in the context of a normal viral infection setting proves to be a challenging endeavor, most likely because of the temporal and ephemeral nature of cell cycle arrest. In the case of KSHV, it has been shown that following K-Rta induction there is a substantial increase in the expression of vCyclin and LANA proteins, both of which have the potential to accelerate cell cycle progression by modulating the Rb-E2F pathway. Clearly, more work is needed to obtain a comprehensive understanding of cell cycle regulation in herpesvirus lytic replication.
In summary, our results demonstrate that KSHV-encoded K-Rta is another player besides K8 that participates in arresting host cells in G 1 phase following viral reactivation. K-Rta-mediated cell cycle arrest was associated with stabilization and increased nuclear accumulation of p27. Our study has revealed a discrete functional role for K-Rta in host cell cycle regulation, which is independent of its function as a major viral transcriptional factor.
